Mikael Sodergren MBChB, DIC, PhD, FRCS is a Senior Clinical Lecturer at Imperial College London and Consultant Hepatobiliary & Pancreatic Surgeon at Imperial College Healthcare NHS Trust.
His clinical interests include complex pancreas, liver & gallbladder cancer surgery as well as laparoscopic & robotic approaches. He was part of the team that pioneered and carried out the first cases of natural orifice translumenal endoscopic surgery (NOTES) in the UK.
His research portfolio is based on novel technological innovation & therapeutics with the following major themes:
1) Immunomodulatory Cancer Therapies with a focus on radiofrequency ablation, saRNA and aptamer technologies applied to hepatocellular carcinoma and pancreatic ductal adenocarcinoma
2) He leads the Medical Cannabis Research Group - a research programme which evaluates and develops novel therapies targeting the endocannabinoid system through a framework of in vitro, in vivo and clinical translational activities
4) Medical Eye-Tracking - investigating the innovative application of this technology to improve outcomes in patients undergoing surgery and other medical interventions
et al., 2021, PRIME-HCC: Phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma, Bmc Cancer, ISSN:1471-2407
et al., 2021, Cannabis-based medicines and pain: a review of potential synergistic and entourage effects, Pain Management, ISSN:1758-1869
et al., 2020, Prognostic relevance of the posterior resection margin for predicting disease free survival in ampullary adenocarcinoma, Surgical Oncology-oxford, Vol:35, ISSN:0960-7404, Pages:211-217
et al., 2020, Comparison of surgeon gaze behaviour against objective skill assessment in laparoscopic cholecystectomy-a prospective cohort study, International Journal of Surgery, Vol:82, ISSN:1743-9159, Pages:149-155
et al., 2020, No difference in mortality among ALPPS, two-staged hepatectomy, and portal vein embolization/ligation: A systematic review by updated traditional and network meta-analyses, Hepatobiliary & Pancreatic Diseases International, Vol:19, ISSN:1499-3872, Pages:411-419